Stephen Cleary - Concepedia

Author

Stephen Cleary

University of California San Diego

Also Known As

S Cleary, S M Cleary, S. Cleary, Stephen Cleary

Publications

852

Citations

H-Index

Concepts

All Affiliations

University of California San Diego

About

Stephen Cleary is an author at University of California San Diego specializing in medicine, oncology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	739
2	Health Sciences	3	3	174
3	Engineering	1	1	25
4	Biochemistry	1	1	20
5	Environmental Engineering	1	1	25

Stephen Cleary

Publications

844

Citations

H-Index

Page 1

	Year	Citations
Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. Stephen B. Howell, Solomon Zimm, Maurie Markman, Journal of Clinical Oncology Residual DiseaseSmall-volume DiseaseIntraperitoneal ChemotherapyGastrointestinal OncologyMedian Survival	1987	221
Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide. Solomon Zimm, Stephen Cleary, William E. Lucas, PubMed Phase I/pharmacokinetic StudyEtoposide ExposurePeritoneal DialysisMedicinePharmacology	1987	83
Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma Maurie Markman, Stephen Cleary, C E Pfeifle, Cancer Surgical OncologyPathologyMultimodalitySurgeryMetronomic Chemotherapy	1986	83
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement Paul J. Karanicolas, Peter Metrakos, Kelvin Chan, Current Oncology Surgical OncologyGastroenterologySurgeryPharmacotherapyMetronomic Chemotherapy	2013	75
Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity. Maurie Markman, Stephen Cleary, William E. Lucas, Journal of Clinical Oncology UrologyIntraperitoneal ChemotherapyBone Marrow SuppressionRefractory Ovarian CarcinomaMedicine	1985	63
Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection Maurie Markman, Stephen Cleary, Stephen B. Howell European Journal of Cancer and Clinical Oncology UrologyMedicineIntravenous Thiosulfate ProtectionPharmacotherapyAcute Kidney Injury	1985	51
Complications of extensive adhesion formation after intraperitoneal chemotherapy. Maurie Markman, Stephen Cleary, Howell Sb, PubMed Colorectal SurgeryMedicineInduced Adhesion FormationGastroenterologyPathology	1986	41
High-dose intracavitary cisplatin with intravenous thiosulfate. Low incidence of serious neurotoxicity Maurie Markman, Stephen Cleary, C E Pfeifle, Cancer	1985	39
Cisplatin and cytarabine administered intrapleurally as treatment of malignant pleural effusions Maurie Markman, Stephen Cleary, M E King, Medical and Pediatric Oncology	1985	30
Plasma uridine changes in cancer patients treated with the combination of dipyridamole and N-phosphonacetyl-L-aspartate. Thomas Chan, Maurie Markman, Stephen Cleary, PubMed UrologyOncologyGenitourinary CancerMedicineMetronomic Therapy	1986	25

Page 1